Impact of meningococcal C conjugate vaccination campaign in Emilia-Romagna, Italy

References

• Caugant DA, Maiden MC. Meningococcal carriage and disease--population biology and evolution. Vaccine 2009; 27:Suppl 2 B64 - 70; http://dx.doi.org/10.1016/j.vaccine.2009.04.061; PMID: 19464092
   PubMed Web of Science ®Google Scholar
• Germinario C, Tafuri S, Napoli C, Montagna MT, Balducci MT, Fortunato F, Martinelli D, Prato R. Young-adult carriers of Neisseria meningitidis in Puglia (Italy): will the pattern of circulating meningococci change following the introduction of meningococcal serogroup C conjugate vaccines?. Hum Vaccin 2010; 6:1025 - 7; http://dx.doi.org/10.4161/hv.6.12.13145; PMID: 21150271
   PubMed Web of Science ®Google Scholar
• Dickinson FO, Pérez AE, Cuevas IE. Meningococcal disease serogroup C. Risk Manag Healthc Policy 2012; 5:1 - 15; http://dx.doi.org/10.2147/RMHP.S12711; PMID: 22427737
   PubMedGoogle Scholar
• 2012 Annual Epidemiological Report, 6th Edition http://www.ecdc.europa.eu/en/publications/Publications/Annual-Epidemiological-Report-2012.pdf.
   Google Scholar
• Balmer P, Borrow R, Miller E. Impact of meningococcal C conjugate vaccine in the UK. [Review] J Med Microbiol 2002; 51:717 - 22; PMID: 12358061
   PubMed Web of Science ®Google Scholar
• de Greeff SC, de Melker HE, Spanjaard L, Schouls LM, van Derende A. Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands. Pediatr Infect Dis J 2006; 25:79 - 80; http://dx.doi.org/10.1097/01.inf.0000195594.41449.c6; PMID: 16395110
   PubMed Web of Science ®Google Scholar
• de Voer RM, Mollema L, Schepp RM, de Greeff SC, van Gageldonk PG, de Melker HE, Sanders EA, Berbers GA, van der Klis FR. Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine. PLoS One 2010; 5:e12144; http://dx.doi.org/10.1371/journal.pone.0012144; PMID: 20730091
   PubMed Web of Science ®Google Scholar
• Martínez AI, Dominguez A, Oviedo M, Minguell S, Jansa JM, Codina G, Vazquez JA, Meningococcal Disease Working Group of Catalonia. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain). Vaccine 2009; 27:3496 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.01.045; PMID: 19200816
   PubMed Web of Science ®Google Scholar
• European Union Invasive Bacterial Infections Surveillance Network (EU-IBIS). Commission of the European Communities Programme on Community action on the prevention of AIDS and certain other communicable diseases. Invasive Neisseria meningitidis in Europe 2006. Available at: http://www.hpa-bioinformatics.org.uk/euibis/documents/2006_meningo.pdf (Accessed October 2013).
   Google Scholar
• Granoff DM, Harrison LH, Pelton S. Meningococcal vaccines. In: Plotkin SA, Orenstein WA, editors. Vaccines. 6th ed. Amsterdam: Saunders Elsevier; 2011.
   Google Scholar
• Protocollo per la sorveglianza nazionale delle malattie invasive da meningococco, pneumococco ed emofilo in Italia (12/3/2007). http://www.simi.iss.it/meningite_batterica.htm
   Google Scholar
• Alfonsi V, D’Ancona F, Giambi C, Nacca G, Rota MC, Regional Coordinators for Infectious Diseases and Vaccinations. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy 2011; 103:176 - 83; http://dx.doi.org/10.1016/j.healthpol.2011.10.002; PMID: 22030308
   PubMed Web of Science ®Google Scholar
• Bechini A, Levi M, Boccalini S, Tiscione E, Balocchini E, Canessa C, Azzari C, Bonanni P. Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy. Vaccine 2012; 30:6396 - 401; http://dx.doi.org/10.1016/j.vaccine.2012.08.019; PMID: 22921931
   PubMed Web of Science ®Google Scholar
• Coperture vaccinali nell’infanzia e nell’adolescenza – Anno 2012, Regione Emilia-Romagna – Assessorato Politiche per la Salute http://www.saluter.it/documentazione/rapporti/vaccinazioni_infanzia_settembre2013.pdf
   Google Scholar
• Chiappini E, Venturini E, Bonsignori F, Galli L, de Martino M. Serogroup C Neisseria meningitidis invasive infection: analysis of the possible vaccination strategies for a mass campaign. [Review] Acta Paediatr 2010; 99:1609 - 14; http://dx.doi.org/10.1111/j.1651-2227.2010.01908.x; PMID: 20545931
   PubMed Web of Science ®Google Scholar
• Richmond P, Borrow R, Goldblatt D, Findlow J, Martin S, Morris R, Cartwright K, Miller E. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis 2001; 183:160 - 3; http://dx.doi.org/10.1086/317646; PMID: 11078484
   PubMed Web of Science ®Google Scholar
• Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004; 364:365 - 7; http://dx.doi.org/10.1016/S0140-6736(04)16725-1; PMID: 15276396
   PubMed Web of Science ®Google Scholar
• https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book.
   Google Scholar
• Borrow R, Abad R, Trotter C, van der Klis FR, Vazquez JA. Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine 2013; 31:4477 - 86; http://dx.doi.org/10.1016/j.vaccine.2013.07.083; PMID: 23933336
   PubMed Web of Science ®Google Scholar
• Hamlin J, Senthilnathan S, Bernstein HH. Update on universal childhood immunizations. Curr Opin Pediatr 2008; 20:483 - 9; http://dx.doi.org/10.1097/MOP.0b013e328306ebd1; PMID: 18622208
   PubMed Web of Science ®Google Scholar
• Velentgas P, Bohn RL, Brown JS, Chan KA, Gladowski P, Holick CN, Kramer JM, Nakasato C, Spettell CM, Walker AM, et al. A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study. Pharmacoepidemiol Drug Saf 2008; 17:1226 - 34; http://dx.doi.org/10.1002/pds.1675; PMID: 18956428
   PubMed Web of Science ®Google Scholar
• De Wals P, Trottier P, Pépin J. Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation. Vaccine 2006; 24:3500 - 4; http://dx.doi.org/10.1016/j.vaccine.2006.02.010; PMID: 16517032
   PubMed Web of Science ®Google Scholar
• Ishola DA Jr., Borrow R, Findlow H, Findlow J, Trotter C, Ramsay ME. Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction. Clin Vaccine Immunol 2012; 19:1126 - 30; http://dx.doi.org/10.1128/CVI.05655-11; PMID: 22647271
   PubMed Web of Science ®Google Scholar
• Snape MD, Kelly DF, Lewis S, Banner C, Kibwana L, Moore CE, Diggle L, John T, Yu LM, Borrow R, et al. Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study. BMJ 2008; 336:1487 - 91; http://dx.doi.org/10.1136/bmj.39563.545255.AE; PMID: 18535032
   PubMed Web of Science ®Google Scholar
• de Voer RM, Mollema L, Schepp RM, de Greeff SC, van Gageldonk PG, de Melker HE, Sanders EA, Berbers GA, van der Klis FR. Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine. PLoS One 2010; 5:e12144; http://dx.doi.org/10.1371/journal.pone.0012144; PMID: 20730091
   PubMed Web of Science ®Google Scholar
• Pollard AJ, Perrett KP, Beverley PC. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol 2009; 9:213 - 20; http://dx.doi.org/10.1038/nri2494; PMID: 19214194
   PubMed Web of Science ®Google Scholar
• Campbell H, Andrews N, Borrow R, Trotter C, Miller E. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin Vaccine Immunol 2010; 17:840 - 7; http://dx.doi.org/10.1128/CVI.00529-09; PMID: 20219881
   PubMed Web of Science ®Google Scholar